We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,231
Increased
3,688
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FOCT icon
6901
FT Vest US Equity Buffer ETF October
FOCT
$1.18B
$37.1K ﹤0.01%
892
+585
+191% +$23.9K
CLRB icon
6902
Cellectar Biosciences
CLRB
$20.1M
$37K ﹤0.01%
493
+295
+149% +$28.3K
AGPU
6903
Axe Compute Inc
AGPU
$96.3M
$37K ﹤0.01%
2,371
+2,287
+2,723% +$52.1K
BCG
6904
Binah Capital Group
BCG
$23.7M
$37K ﹤0.01%
+5,963
New +$41K
SMX icon
6905
SMX (Security Matters) Plc
SMX
$18.3M
0
ROOF
6906
DELISTED
NYLI CBRE NextGen Real Estate ETF
ROOF
$36.9K ﹤0.01%
1,935
-163
-8% -$3.09K
NODK icon
6907
NI Holdings
NODK
$318M
$36.9K ﹤0.01%
2,412
-5,617
-70% -$85.1K
CTXR icon
6908
Citius Pharmaceuticals
CTXR
$17.6M
$36.7K ﹤0.01%
2,511
-2,874
-53% -$51.5K
VLU icon
6909
State Street SPDR S&P 1500 Value Tilt ETF
VLU
$767M
$36.7K ﹤0.01%
213
-5,947
-97% -$1.02M
BOLT icon
6910
Bolt Biotherapeutics
BOLT
$7.44M
$36.6K ﹤0.01%
2,441
+1,832
+301% +$36.1K
LILM
6911
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
$36.6K ﹤0.01%
46,046
+45,946
+45,946% +$43.1K
AUGX
6912
DELISTED
Augmedix, Inc. Common Stock
AUGX
$36.4K ﹤0.01%
41,414
+22,314
+117% +$46K
ATAI icon
6913
AtaiBeckley Inc
ATAI
$2.66B
$36.3K ﹤0.01%
27,328
+2,450
+10% +$4.41K
HYDB icon
6914
iShares High Yield Systematic Bond ETF
HYDB
$1.6B
$36.3K ﹤0.01%
781
-982
-56% -$45.4K
HDL
6915
Super Hi International Holding
HDL
$36.3K ﹤0.01%
+2,015
New +$38.5K
ETON icon
6916
Eton Pharmaceutcials
ETON
$1.26B
$36.2K ﹤0.01%
11,018
+9,058
+462% +$31.7K
EDOG icon
6917
ALPS Emerging Sector Dividend Dogs ETF
EDOG
$29.6M
$36.2K ﹤0.01%
1,737
-709
-29% -$15.1K
VTES icon
6918
Vanguard Short-Term Tax-Exempt Bond ETF
VTES
$2.08B
$36.1K ﹤0.01%
361
-189
-34% -$18.9K
APIE icon
6919
ActivePassive International Equity ETF
APIE
$1.16B
$36.1K ﹤0.01%
+1,268
New +$36K
HYDW icon
6920
Xtrackers Low Beta High Yield Bond ETF
HYDW
$67.4M
$36.1K ﹤0.01%
783
-278
-26% -$12.7K
JULQ
6921
DELISTED
Innovator Premium Income 40 Barrier ETF July
JULQ
$36.1K ﹤0.01%
1,454
+499
+52% +$12.5K
GHSI
6922
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$36.1K ﹤0.01%
3,593
+2,421
+207% +$21.5K
CHNR icon
6923
China Natural Resources
CHNR
$4.77M
$36K ﹤0.01%
5,747
+5,055
+730% +$39.1K
XFOR icon
6924
X4 Pharmaceuticals
XFOR
$393M
$36K ﹤0.01%
2,068
-2,235
-52% -$73.1K
JUNW icon
6925
AllianzIM U.S. Equity Buffer20 Jun ETF
JUNW
$376M
$36K ﹤0.01%
1,258
+1,195
+1,897% +$33.6K

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.